KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Times Interest Earned (2018 - 2020)

Historic Times Interest Earned for Xenon Pharmaceuticals (XENE) over the last 4 years, with Q2 2020 value amounting to -$4.19.

  • Xenon Pharmaceuticals' Times Interest Earned rose 8543.47% to -$4.19 in Q2 2020 from the same period last year, while for Mar 2021 it was -$255.37, marking a year-over-year decrease of 81842.84%. This contributed to the annual value of -$64.67 for FY2020, which is 11658.36% down from last year.
  • According to the latest figures from Q2 2020, Xenon Pharmaceuticals' Times Interest Earned is -$4.19, which was up 8543.47% from -$24.34 recorded in Q1 2020.
  • In the past 5 years, Xenon Pharmaceuticals' Times Interest Earned registered a high of -$4.19 during Q2 2020, and its lowest value of -$49.09 during Q1 2018.
  • Its 3-year average for Times Interest Earned is -$28.46, with a median of -$28.8 in 2019.
  • Per our database at Business Quant, Xenon Pharmaceuticals' Times Interest Earned crashed by 1785.14% in 2019 and then surged by 8543.47% in 2020.
  • Over the past 3 years, Xenon Pharmaceuticals' Times Interest Earned (Quarter) stood at -$20.92 in 2018, then tumbled by 59.28% to -$33.33 in 2019, then surged by 87.41% to -$4.19 in 2020.
  • Its Times Interest Earned was -$4.19 in Q2 2020, compared to -$24.34 in Q1 2020 and -$33.33 in Q4 2019.